IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
68 hedge funds and large institutions have $44.9M invested in IVERIC bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 12 closing their positions.
192% more call options, than puts
Call options by funds: $455K | Put options by funds: $156K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 73 → 68 (-5)
19% less capital invested
Capital invested by funds: $55.6M → $44.9M (-$10.8M)
28% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 25
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.03M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$770K |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$354K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$261K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$227K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.01M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$958K |
| 3 |
Renaissance Technologies
New York
|
-$751K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$398K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$363K |
ISEE Hedge Fund Activity: Q3 2018 in Review
68 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2018, worth a combined $44.9M — down 19% from $55.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ISEE and 8 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 18 added.
The largest buyer was Stonepine Capital Management, adding an estimated $1.03M. The largest seller was Deutsche Bank, cutting an estimated $1.01M.
- 68 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2018, down from 73 in Q2 2018.
- Funds reported $44.9M of IVERIC bio, Inc. Common Stock stock for Q3 2018, down 19% quarter-over-quarter.
- 8 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2018 and 12 closed out, a net change of -4 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q3 2018 was Stonepine Capital Management, an estimated $1.03M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q3 2018 was Deutsche Bank, an estimated $1.01M sold.
Based on aggregated 13F filings for Q3 2018.